Severe Eczematous Skin Reaction After High-Dose Intravenous Immunoglobulin Infusion | Zendy

G Vecchietti | Zendy; Katrin Kerl | Zendy; Christa Prins | Zendy; Gürkan Kaya | Zendy; JeanHilaire Saurat | Zendy; Lars E. French | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Severe Eczematous Skin Reaction After High-Dose Intravenous Immunoglobulin Infusion

Author(s) -

G Vecchietti,

Katrin Kerl,

Christa Prins,

Gürkan Kaya,

JeanHilaire Saurat,

Lars E. French

Publication year - 2006

Publication title -

archives of dermatology

Language(s) - English

Resource type - Journals

eISSN - 1538-3652

pISSN - 0003-987X

DOI - 10.1001/archderm.142.2.213

Subject(s) - medicine , rash , dermatology , maculopapular rash , adverse effect , eczematous dermatitis , dermatomyositis

High-dose intravenous immunoglobulins (IVIGs) are increasingly used to treat inflammatory and/or autoimmune disorders. In dermatology, they provide therapeutic benefit in Kawasaki disease and certain cases of dermatomyositis. While most adverse effects following IVIG treatment are not severe, occasionally more severe adverse effects occur, including anaphylactic reactions and acute, usually transient, renal failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research